Irving-based Caris Life Sciences began the commercial launch of Caris Detect, a blood test designed to detect signals for multiple types of cancer earlier than previously possible.
Early detection is key to improving cancer outcomes for patients. Overall five-year cancer survival has climbed to 70%, according to the American Cancer Society’s Cancer Facts & Figures 2026 report....




